Pharmacy Benefits Management Services Home

18 Other AEs reported during the clinical trial at a frequency of ≥5% to 10% were gastroesophageal reflux, abdominal pain, asthenia, malaise, thirst, increased blood triglycerides, hypoglycemia, muscular weakness, flank pain, musculoskeletal chest pain, insomnia, vaginal hemorrhage, metrorrhagia. ................
................